Baity Glenn

Avg. Two Year Performance

No purchase track record
(22%) Avg. Sale Return
(11%) Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return----------
Purchase Success Rate----------
Average Sale Return2%2%1%(10%)(22%)
Sale Success Rate6 of 127 of 127 of 125 of 123 of 12

Acadia Pharmaceuticals Inc.

Drugs » Biotechnology

EVP AND GC:

Holdings: 83.73K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--